Cisatracurium Kabi (Cisatracurium Besilate)

Cisatracurium Besilate is a neuromuscular blocking agent used for muscle relaxation during surgical procedures. It is administered intravenously and is manufactured by Fresenius Kabi Hungary Kft.

Cisatracurium Besilate is primarily used to facilitate endotracheal intubation and provide skeletal muscle relaxation during surgery. It is often employed in operating rooms to help surgeons perform procedures more easily by temporarily paralyzing muscles. This medication is commonly used in what is known as general anesthesia to ensure the patient remains still and relaxed.

Cisatracurium Besilate works by blocking the action of acetylcholine at the neuromuscular junction, leading to muscle relaxation. Common effects include temporary paralysis of skeletal muscles, which is intended to facilitate surgical procedures. The duration of these effects varies depending on the dosage and individual patient factors.

Cisatracurium Besilate should be administered by healthcare professionals in a controlled medical setting. It is important to monitor the patient's respiratory function closely, as the medication can cause temporary paralysis of the respiratory muscles. Patients with certain medical conditions, such as severe liver or kidney disease, may require special precautions.

Cisatracurium Besilate may interact with other medications that affect neuromuscular function, including certain anesthetics and antibiotics. It is important to inform healthcare providers about all medications being taken to avoid potential interactions. Additionally, the effects of Cisatracurium Besilate may be prolonged in patients taking certain medications that inhibit liver enzymes.